EANM procedure guidelines for treatment of refractory metastatic bone pain.
Silberstein
Edward B
EB
University of Cincinnati Medical Center, Ohio, USA.
Taylor
Andrew T
AT
D001859:Bone Neoplasms / Q000150:complications / Q000175:diagnosis / Q000532:radiotherapy* / Q000556:secondary*; D012968:Etidronic Acid / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D009683:Nuclear Medicine / Q000592:standards; D009942:Organometallic Compounds / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010148:Intractable Pain / Q000209:etiology / Q000532:radiotherapy*; D010166:Palliative Care / Q000379:methods / Q000592:standards*; D018579:Patient Selection; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011878:Radiotherapy / Q000379:methods / Q000592:standards*; D012211:Rhenium / Q000627:therapeutic use*; D012955:Societies, Medical / Q000592:standards; D016896:Treatment Outcome
D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D019275:Radiopharmaceuticals; C101598:rhenium-186 HEDP; D012211:Rhenium; C061972:samarium Sm-153 lexidronam; D012968:Etidronic Acid